# Forte Biosciences, Inc. (FBRX)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/FBRX/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -45.47M | $ -41.51M | $ 0 | $ 183.79M |
| 2025 | $ 0 | $ -71.03M | $ -52.22M | $ 0 | $ 60.99M |
| 2024 | $ 0 | $ -37.29M | $ -32.35M | $ 0 | $ 52.48M |
| 2023 | $ 0 | $ -34.03M | $ -31.13M | $ 0 | $ 35.31M |
| 2022 | $ 0 | $ -15.53M | $ -9.14M | $ 0 | $ 38.82M |
| 2021 | $ 0 | $ -25.80M | $ -19.82M | $ 0 | $ 41.55M |
| 2020 | $ 0 | $ -59.22M | $ -23.47M | $ 0 | $ 58.98M |
| 2019 | $ 23.2K | $ -16.89M | $ -4.12M | $ 0 | $ 5.75M |
| 2018 | $ 0 | $ -64.65M | $ -35.45M | $ 26.20M | $ 58.15M |
| 2017 | $ 0 | $ -52.44M | $ -10.27M | $ 10.83M | $ 71.08M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.00 |
| Liabilities / Eq | 0.12 |
| Current Ratio | 10.01 |

## Other views

- [Metrics](https://sponda.capital/en/FBRX.md)
- [Charts](https://sponda.capital/en/FBRX/charts.md)
- [Compare](https://sponda.capital/en/FBRX/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.